GLP-1s also help reduce disordered eating including reduced emotional eating, less eating in response to external triggers, less binge eating, loss-of-control eating and food rumination
For patients who want to transition from a compounded product to an FDA-approved one, both clinicians cautioned that the process isnt always straightforward, as it may not be clear what dose a patient on a compounded product had been taking
Compounded semaglutide is created by licensed pharmacies using the same active ingredient (semaglutide), but its not FDA-approved
Signs Patients and Clinicians Should Not Ignore A GLP-1 user should not assume that every new symptom is just part of the adjustment. Depending on the individual, poor intake and nutrient depletion may contribute to fatigue, weakness, reduced exercise tolerance, hair changes, muscle cramps, lightheadedness, poor recovery, or worsening physical performance